Automated enumeration and phenotypic characterization of CTCs and tdEVs in patients with metastatic castration resistant prostate cancer

BACKGROUND: Although most patients with metastatic castration-resistant prostate cancer (mCRPC) initially benefit from treatment with androgen receptor signaling inhibitors (ARSi), resistance inevitably occurs. Hence, we investigated the prognostic value of automated circulating tumor cell (CTC) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Oeyen, Steffi, Liégeois, Vincent, De Laere, Bram, Buys, Andy, Strijbos, Michiel, Dirix, Piet, Meijnders, Paul, Vermeulen, Peter, Van Laere, Steven, Dirix, Luc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134056/
https://www.ncbi.nlm.nih.gov/pubmed/33230201
http://dx.doi.org/10.1038/s41391-020-00304-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134056/
https://www.ncbi.nlm.nih.gov/pubmed/33230201
http://dx.doi.org/10.1038/s41391-020-00304-1

Ejemplares similares